Scholarrock

Scholar Rock is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and delivering therapies that create new possibilities for patients suffering from rare neuromuscular diseases. The company is preparing for potential FDA and EMA approval of apitegromab for the treatment of children and adults living with spinal muscular atrophy (SMA).